• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

Global wearable patch market growing at 10.6% rate

February 22, 2021 By Sean Whooley

G6

Researchers say that the global wearable patch market size is expected to reach $12.6 billion by 2026, marking a massive rise over five years. According to the research, put together by ResearchAndMarkets.com, the rise is expected to represent a compound annual growth rate of 10.6% during the forecast period. Wearables covered by the research, including […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: abbott, Dexcom, Eli Lilly & Co., Insulet, sanofi, wearables

AmacaThera raises $10.3M in oversubscribed Series A

February 22, 2021 By Sean Whooley

AmacaThera announced today that it completed an oversubscribed $10.3 million Series A financing round. Lumira Ventures led the Series A funding, with existing investors Viva BioInnovator and Sprout BioVentures contributing as well. New investors BDC Capital Women in Technology Venture Fund, Inveready, MBX Capital, CR Capital Management, StandUp Ventures and MaRS IAF participated, too, according […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Hydrogels, Pain Management, Pharmaceuticals, Surgical Tagged With: AmacaThera

ForDoz enters manufacturing agreement with LipoMedix

February 19, 2021 By Sean Whooley

ForDoz Pharma announced today that it entered into an agreement with LipoMedix to manufacture its lead compound for a clinical trial. LipoMedix’s pegylated liposomal Promitil (PL-MLP) is designed for the selective delivery of the therapeutic agent to cancer-affected tissues and is suited for cancer chemoradiotherapy, according to a news release. Studies have shown PL-MLP to […]

Filed Under: Business/Financial News, Contract Services, Featured, Oncology, Pharmaceuticals Tagged With: ForDoz, LipoMedix

Acorda Therapeutics announces departure of business operations chief

February 19, 2021 By Sean Whooley

Acorda Therapeutics (NSDQ:ACOR) announced today that its chief of business operations, David Lawrence, is resigning from the company. Lawrence, who also serves as Acorda’s principal accounting and financial officer, is resigning effective mid-March 2021 as he is set to take a leadership position at an early-stage biotechnology company, according to a news release. “Dave has […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Neurological, Pharmaceuticals Tagged With: Acorda Therapeutics, Personnel, Personnel Moves

Evox Therapeutics completes $95.4M Series C

February 18, 2021 By Sean Whooley

Evox Therapeutics

Evox Therapeutics announced today that it raised $95.4 million (£69.2 million) in a Series C financing round. Oxford, England-based Evox’s financing was significantly oversubscribed with high demand from both existing and new investors, according to a news release. Redmile Group led the financing while being joined by new investors OrbiMed and Invus. OrbiMed partner Chau […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Pharmaceuticals, Research & Development Tagged With: Eli Lilly & Co., evoxtherapeutics, Takeda Pharmaceutical Co

Lyra Therapeutics names new chief medical officer

February 17, 2021 By Sean Whooley

Lyra Therapeutics (NSDQ:LYRA) announced today that it appointed Dr. Robert Kern as its new chief medical officer. Kern will remain in his current position as the George A. Sisson Professor and Chair, Department of Otolaryngology – Head and Neck Surgery at the Northwestern University Feinberg School of Medicine while operating as Lyra’s CMO, according to […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Otolaryngology Ear, Nose & Throat, Pharmaceuticals Tagged With: Lyra Therapeutics, Personnel Moves

NuTec, Epson combine to automate syringe production

February 17, 2021 By Sean Whooley

Epson Robots announced today that NuTec Tooling Systems built a syringe coating machine in an effort that includes four Epson robots. The four Epson Cleanroom SCARA robots for a pharmaceutical OEM are employed at various stations within the machine to offer automation to the customer’s syringe manufacturing process, according to a news release. Carson, Calif.-based […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured Tagged With: Epson, NuTec Tooling Systems

Retractable Technologies lands $54.2M federal contract for syringes

February 17, 2021 By Sean Whooley

RTI-NEW-Logo-Retractable-Technologies

Retractable Technologies (NYSE:RVP) announced that it received a government contract worth more than $54.2 million for its syringes. Little Elm, Texas-based Retractable Technologies’ contract and purchase order was made by the U.S. Health & Human Services Dept. (HHS) with a base price of $54,217,800 for a five-month period between Feb. 15, 2021, and July 14, 2021. […]

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured Tagged With: HHS, Retractable Technologies, syringes

BD wins Frost & Sullivan innovation award for Intevia autoinjector

February 16, 2021 By Sean Whooley

Frost & Sullivan announced today that it recognizes Becton Dickinson (NYSE:BDX) with a 2020 Global Technology Innovation Award. BD received the award for its Intevia autoinjector, which, as part of the company’s differentiated self-injection systems portfolio, facilitates high-viscosity biologics delivery for treating chronic diseases, according to a news release. Intevia, a two-step, push-on-skin, handheld autoinjector delivers […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Becton Dickinson, Frost & Sullivan

Report: Global syringes market set to reach $32.4B by 2027

February 12, 2021 By Sean Whooley

Market research released this week suggests that the global syringes market will reach $32.39 billion by 2027. Allied Market Research published a report estimating the global syringes market sat at $15.34 billion in 2019, with expectations of hitting $32.39 billion in value by 2027, with a compound annual growth rate (CAGR) of 9.6% from 2020 […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: bbraun, Becton Dickinson, Cardinal Health, Medline Industries, Retractable Technologies, syringes, Terumo Corp.

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 54
  • Go to page 55
  • Go to page 56
  • Go to page 57
  • Go to page 58
  • Interim pages omitted …
  • Go to page 71
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS